Severe obesity is already a significant problem for many children, especially since obese children often become obese adults.

Children who used the weight loss drug liraglutide in a late-stage trial lost significantly more weight than children who got ...

Researchers found that patients with obesity had an average weight loss of 12.9% with semaglutide vs 5.6% with liraglutide ...

Injectable prescription drugs that reduce appetite — like Ozempic, Saxenda and Mounjaro — have skyrocketed in popularity in ...

Evidence shows that blockbuster weight-loss medications can reduce obesity even in children aged 6–11, but their long-term ...

While many consumers have hopped on the Ozempic bandwagon in recent months to help them lose weight, few studies have looked ...

The average age being 10, and the average weight being 155 lbs.56 were given the drug, and 26 were given a placebo.In ...

The obesity medication liraglutide is safe and effective in children aged 6 to <12 years, new research being presented at the ...

Liraglutide treatment significantly lowers BMI in obese children aged 6 to <12, but gastrointestinal side effects prompt the ...

Among patients receiving persistent medication at one year, 61% of patients prescribed semaglutide for obesity achieved at ...

The weight-loss drug liraglutide (Saxenda) helped obese children lower their BMI and reach a healthier weight, researchers ...

A drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6 when combined with ...